Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has launched Aerolife ...

New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD exacerbation with a dry powder inhaler vs. a metered-dose or soft mist ...

Zydus Lifesciences launches Aerolife Mini, to simplify inhaler use for asthma and COPD patients: Our Bureau, Mumbai Thursday, March 19, 2026, 13:15 Hrs [IST] Zydus Lifesciences Li ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

Nearly one million Israelis live with chronic lung diseases such as asthma and COPD, and for them the current security ...

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads ...

Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...

A202, a design-led innovation, is launched in an exclusive marketing arrangement with Zydus Lifesciences Limited • The launch marks ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

AeroDel Technology Innovations Pvt. Ltd., a Mumbai-based respiratory medical device company, announces an exclusive licensing arrangement with Zydus Lifesciences Limited for the commercial pan-India ...